OR7E145P

Across TCGA pan-cancer cohorts, OR7E145P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated OR7E145P data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher OR7E145P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR7E145P expression acts as an unfavorable survival marker, although some lineages such as LUAD and UCS show a favorable association.

LUSC, KIRP, and ACC are the cancer types where OR7E145P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Quartile	All	0.621	0.850	<.001	50	view →
KIRP	OS	Tertile	II,III,IV	0.161	0.771	.002	39	view →
ACC	DFS	Tertile	II,III,IV	0.102	0.605	.004	27	view →
CHOL	OS	Tertile	II,III,IV	0.019	0.765	.001	27	view →
LUAD	DFS	Tertile	II,III,IV	0.573	0.177	.008	21	view →
PCPG	DFS	Tertile	All	0.352	0.842	<.001	18	view →
MESO	OS	Tertile	IV	0.077	0.592	.019	18	view →
LIHC	OS	Tertile	II,III,IV	0.118	0.622	.004	18	view →
UCS	OS	Median	II,III,IV	0.590	0.268	.019	14	view →
SARC	OS	Tertile	All	1.000	0.441	.018	12	view →
SKCM	OS	Tertile	IV	0.415	0.861	.014	9	view →
UCEC	DFS	Quartile	All	0.441	0.720	.020	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

OR7E145P–LUSC (OS)

Open the LUSC breakdown →